WO2003095630A2 - Peau bioartificielle - Google Patents

Peau bioartificielle Download PDF

Info

Publication number
WO2003095630A2
WO2003095630A2 PCT/EP2003/004784 EP0304784W WO03095630A2 WO 2003095630 A2 WO2003095630 A2 WO 2003095630A2 EP 0304784 W EP0304784 W EP 0304784W WO 03095630 A2 WO03095630 A2 WO 03095630A2
Authority
WO
WIPO (PCT)
Prior art keywords
fibroblasts
protein
growth factor
skin
autologous
Prior art date
Application number
PCT/EP2003/004784
Other languages
German (de)
English (en)
Other versions
WO2003095630A3 (fr
Inventor
Hans-Günther Machens
Original Assignee
Machens Hans-Guenther
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Machens Hans-Guenther filed Critical Machens Hans-Guenther
Priority to EP03732323A priority Critical patent/EP1504087A2/fr
Priority to AU2003239844A priority patent/AU2003239844A1/en
Publication of WO2003095630A2 publication Critical patent/WO2003095630A2/fr
Publication of WO2003095630A3 publication Critical patent/WO2003095630A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/091—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells melanocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne une peau bioartificielle présentant une matrice poreuse sur laquelle se trouvent des fibroblastes isogènes ou autologues qui expriment au moins une protéine angiogénétique, une protéine neurotrophe et au moins une protéine stabilisant la jonction épidermo-dermale ainsi que la formation d'un épiderme conforme au coloris, un mélange de kératinocytes et mélanocytes isogènes ou autologènes, leur procédé de production et leur utilisation.
PCT/EP2003/004784 2002-05-07 2003-05-07 Peau bioartificielle WO2003095630A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03732323A EP1504087A2 (fr) 2002-05-07 2003-05-07 Peau bioartificielle
AU2003239844A AU2003239844A1 (en) 2002-05-07 2003-05-07 Bioartificial skin comprising genetically modified fibroblasts

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10220472A DE10220472A1 (de) 2002-05-07 2002-05-07 Bioartifizielle Haut
DE10220472.1 2002-05-07

Publications (2)

Publication Number Publication Date
WO2003095630A2 true WO2003095630A2 (fr) 2003-11-20
WO2003095630A3 WO2003095630A3 (fr) 2004-03-04

Family

ID=29285189

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/004784 WO2003095630A2 (fr) 2002-05-07 2003-05-07 Peau bioartificielle

Country Status (4)

Country Link
EP (1) EP1504087A2 (fr)
AU (1) AU2003239844A1 (fr)
DE (1) DE10220472A1 (fr)
WO (1) WO2003095630A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006123004A1 (fr) 2005-05-16 2006-11-23 Fundación Para La Investigación Biomédica Del Hospital Gregorio Marañon Matrice artificielle de gel de fibrine envahie de cellules endotheliales superproductrices de facteurs pro-angiogeniques
CN101955908A (zh) * 2010-07-22 2011-01-26 中国医学科学院皮肤病研究所 用于检测物质致敏性和药物筛选的人工表皮体外模型

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512475A (en) * 1986-04-18 1996-04-30 Advanced Tissue Sciences, Inc. Three-dimensional skin cell and tissue culture system
WO1999045770A1 (fr) * 1998-03-09 1999-09-16 The Board Of Trustees Of The Leland Stanford Junior University Equivalent de peau et procedes de formation et d'utilisation
WO2000029553A1 (fr) * 1998-11-19 2000-05-25 Organogenesis Inc. Constructions tissulaires transgeniques et procedes de production et d'utilisation associes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512475A (en) * 1986-04-18 1996-04-30 Advanced Tissue Sciences, Inc. Three-dimensional skin cell and tissue culture system
WO1999045770A1 (fr) * 1998-03-09 1999-09-16 The Board Of Trustees Of The Leland Stanford Junior University Equivalent de peau et procedes de formation et d'utilisation
WO2000029553A1 (fr) * 1998-11-19 2000-05-25 Organogenesis Inc. Constructions tissulaires transgeniques et procedes de production et d'utilisation associes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MACHENS, H.-G. ET AL.: "Bioartificial skin" CELLS TISSUES ORGANS, Bd. 167, Nr. 2-3, 2000, Seiten 88-94, XP008022499 in der Anmeldung erw{hnt *
MACHENS, H.-G. ET AL.: "Gentherapeutische Möglichkeiten in der plastischen Chirurgie" DER CHIRURG, Bd. 71, Nr. 2, Februar 2000 (2000-02), Seiten 152-158, XP002256227 *
MACHENS, H.-G. ET AL.: "Platelet-derived growth factor-AA-mediated functional angiogenesis in the rat epigastric island flap after genetic modification of fibroblasts is ischemia dependent" SURGERY, Bd. 131, Nr. 4, April 2002 (2002-04), Seiten 393-400, XP008018381 *
SUPP, D.M. ET AL.: "Genetic modification of cultureed skin substitutes by transduction of human keratinocytes and fibroblasts with platelet-derived growth factor-A" WOUND REPAIR AND REGENERATION, Bd. 8, Nr. 1, 2000, Seiten 26-35, XP001154286 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006123004A1 (fr) 2005-05-16 2006-11-23 Fundación Para La Investigación Biomédica Del Hospital Gregorio Marañon Matrice artificielle de gel de fibrine envahie de cellules endotheliales superproductrices de facteurs pro-angiogeniques
CN101955908A (zh) * 2010-07-22 2011-01-26 中国医学科学院皮肤病研究所 用于检测物质致敏性和药物筛选的人工表皮体外模型

Also Published As

Publication number Publication date
DE10220472A1 (de) 2003-11-27
WO2003095630A3 (fr) 2004-03-04
AU2003239844A8 (en) 2003-11-11
EP1504087A2 (fr) 2005-02-09
AU2003239844A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
EP1242129B1 (fr) Produit de synthese biologique pour articulation
AU731768B2 (en) Composition and method for repairing neurological tissue
CN105517587A (zh) 伤口愈合与组织工程
DE69930155T2 (de) Spray verabreichung von zellen
JPH08509356A (ja) 細胞の移植システム及び方法
Ui et al. Cell lines from imaginal discs of Drosophila melanogaster
US20030091543A1 (en) Therapeutic cell preparation grafts and methods of use thereof
DE69531712T2 (de) Hybridgel, das eine biologisch aktive Substanz sekretiert
DE69725317T2 (de) Implantierbare agarose-kollagenkügelchen enthaltende zellen, die ein diffusionsfähiges biologisches produkt bilden und ihre verwendung
WO1995023216A1 (fr) Mode de preparation de fibroplasts clonogenes, methode de transfection genique de fibroplasts et les fibroplasts genotransfectes ainsi obtenus
DE69233725T2 (de) Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
CN1671836B (zh) 用于基因治疗的原代培养脂肪细胞
EP1286708A1 (fr) Procede de production d'un transplant bio-artificiel
DE60027724T2 (de) Verbesserte keratinozytenkultur und deren verwendungen
DE69824017T2 (de) Vehikel zur gentherapie enthaltend dermales huellgewebe
EP1989293B1 (fr) Constructions de transplantation tissulaire prévascularisées destinées à la reconstruction d'un organe humain ou animal
Schwenter et al. Survival of encapsulated human primary fibroblasts and erythropoietin expression under xenogeneic conditions
WO2004042038A1 (fr) Procede de traitement de tissus malades, degeneres ou endommages faisant appel a un tissu tridimensionnel obtenu in vitro associe a des cellules tissulaires et/ou des facteurs exogenes
EP1504087A2 (fr) Peau bioartificielle
CN113577108B (zh) 一种多功能胶原支架、其制备方法与应用
DE60221519T2 (de) Verfahren und zusammensetzung für hauttransplantate
Sato et al. Artifical Esophagus
DE19651992A1 (de) Serum als Zusatz von Kulturmedium bei der Züchtung von stratifizierten Hautäquivalenten aus Stammzellen
EP1476542A1 (fr) Agent d'induction ou d'inhibition de l'angiogenese
DE10220474A1 (de) Mittel zur Induktion oder Inhibition einer Angiogenese

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003732323

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003732323

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2003732323

Country of ref document: EP